Scarica l'app Stockscreener
0.00
100.00%
-2.72
Precedente Chiudi:
$2.72
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$9.79M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.00
$0.00
Portata 52W:
$0.00
$4.6054
Cosciens Biopharma Inc Stock (CSCI) Company Profile
Nome
Cosciens Biopharma Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta CSCI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CSCI
Cosciens Biopharma Inc
|
0.00 | 9.79M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.38 | 114.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
748.71 | 78.80B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
396.04 | 51.80B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
847.05 | 53.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.55 | 42.33B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cosciens Biopharma Inc Borsa (CSCI) Ultime notizie
(CSCI) Trading Advice (CSCI:CA) - news.stocktradersdaily.com
(CSCI) Technical Pivots with Risk Controls (CSCI:CA) - news.stocktradersdaily.com
MSN Money - MSN
(CSCI) Strategic Investment Guide (CSCI:CA) - news.stocktradersdaily.com
Long Term Trading Analysis for (CSCI) (CSCI:CA) - news.stocktradersdaily.com
Is COSCIENS Biopharma Inc. stock a safe haven assetQuarterly Portfolio Report & Daily Volume Surge Signals - Newser
Why analysts upgrade COSCIENS Biopharma Inc. stockEarnings Summary Report & Entry Point Confirmation Alerts - Newser
Cosciens Biopharma Brief: Announcing Exclusive Distribution Agreement With Wuzhou Drug International For Macrilen In Hainan-Guangdong-Hong Kong-Macao Greater Bay Area And Singapore - MarketScreener
COSCIENS Biopharma Secures Exclusive Distribution Deal for Macrilen® in Asia - TipRanks
COSCIENS Announces Exclusive Distribution Agreement with Wuzhou Drug International for Macrilen® in Hainan-Guangdong-Hong Kong-Macao Greater Bay Area and Singapore - The Manila Times
COSCIENS (TSX: CSCI) gives Wuzhou Macrilen rights, ten-year term, €800,000 order - Stock Titan
How COSCIENS Biopharma Inc. stock performs in rate cut cycles2025 Top Gainers & Capital Efficient Trading Techniques - moha.gov.vn
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week - MSN
(CSCI) Strategic Equity Report (CSCI:CA) - news.stocktradersdaily.com
Tools to assess COSCIENS Biopharma Inc.’s risk profileAnalyst Downgrade & Long Hold Capital Preservation Tips - newser.com
Is COSCIENS Biopharma Inc. stock a safe investment in uncertain marketsWall Street Watch & Low Drawdown Investment Ideas - newser.com
Can COSCIENS Biopharma Inc. stock deliver surprise earnings beat2025 Market Overview & Free Accurate Trade Setup Notifications - newser.com
Chart overlay techniques for tracking COSCIENS Biopharma Inc.Earnings Recap Summary & Smart Money Movement Alerts - newser.com
(CSCI) Dynamic Trading Report (CSCI:CA) - news.stocktradersdaily.com
COSCIENS Biopharma Appoints Peter H. Puccetti as Interim CEO - MarketScreener
COSCIENS Biopharma Names Puccetti Interim CEO After Biehn Resigns - 富途牛牛
How currency fluctuations impact COSCIENS Biopharma Inc. stockQuarterly Trade Summary & Low Drawdown Trading Strategies - newser.com
Will COSCIENS Biopharma Inc. stock see insider buyingExit Point & Weekly Watchlist for Hot Stocks - newser.com
COSCIENS Biopharma appoints interim CEO - MSN
COSCIENS Biopharma Appoints New Interim CEO Amid Strategic Shifts - The Globe and Mail
COSCIENS Biopharma Inc. Announces Leadership Change - Lelezard
Cosciens Biopharma announces leadership change - MarketScreener
Live market analysis of COSCIENS Biopharma Inc.Dividend Hike & Growth Oriented Trading Recommendations - newser.com
COSCIENS Biopharma (TSX: CSCI) appoints Peter Puccetti interim CEO, succeeding Anna Biehn - Stock Titan
Cosciens Biopharma Inc Azioni (CSCI) Dati Finanziari
Non sono disponibili dati finanziari per Cosciens Biopharma Inc (CSCI). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.31%
0.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):